Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
- Authors: Chazova IE1, Valieva ZS1, Nakonechnikov SN1, Taran IN1,2, Martynyuk TV1
-
Affiliations:
- National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseases
- Scientific Research Institute for Complex Issues of Cardiovascular Diseases, Department of Multifocal Atherosclerosis, laboratory of rehabilitation
- Issue: Vol 91, No 9 (2019)
- Pages: 77-87
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33635
- DOI: https://doi.org/10.26442/00403660.2019.09.000343
- ID: 33635
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I E Chazova
National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseasesакад. РАН, проф., д.м.н., директор Института клинической кардиологии, руководитель отд. гипертонии НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России Moscow, Russia
Z S Valieva
National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseases
Email: v.zarina.v@gmail.com
к.м.н., н.с. отд. легочной гипертензии и заболеваний сердца НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России Moscow, Russia
S N Nakonechnikov
National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseasesд.м.н., генеральный директор РМОАГ, проф. каф. кардиологии фак-та ДПО Российского национального исследовательского медицинского университета им. Н.И. Пирогова Moscow, Russia
I N Taran
National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseases; Scientific Research Institute for Complex Issues of Cardiovascular Diseases, Department of Multifocal Atherosclerosis, laboratory of rehabilitationаспирант отд. легочной гипертензии и заболеваний сердца НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России; м.н.с. лаб. реабилитации отд. мультифокального атеросклероза ФГБНУ «НИИ комплексных проблем сердечно-сосудистых заболеваний», Кемерово Moscow, Russia
T V Martynyuk
National Medical Research Center of Cardiology, Myasnikov Scientific Research Institute of Clinical Cardiology, Department of Pulmonary Hypertension and Heart Diseasesд.м.н., руководитель отд. легочной гипертензии и заболеваний сердца НИИ клинической кардиологии им. А.Л. Мясникова ФГБУ «НМИЦ кардиологии» Минздрава России; проф. каф. кардиологии фак-та ДПО Российского национального исследовательского медицинского университета им. Н.И. Пирогова Moscow, Russia
References
- Мартынюк Т.В. Легочная гипертензия: диагностика и лечение. М., 2018. Серия Библиотека ФГБУ «НИМЦ кардиологии» Минздрава России.
- Чазова И.Е., Мартынюк Т.В., Филиппов Е.В. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (1 часть). Терапевтический архив. 2016;88(9):90-101.
- Kim N.H, Delcroix M, Jenkins D.P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62:D92-D99.
- Hoeper M.M, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-20.
- Ghofrani H.A, D’Armini A.M, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319-29.
- Delcroix M, Staehler G, Gall H, et al. Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients. Eur Respir J. 2018;pii:1800248.
- Simonneau G, D’Armini A.M, Ghofrani H.A, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long - term extension study (CHEST-2). Eur Respir J. 2015 May;45(5):1293-302.
- Minai O.A, Bonner N, Mathai S.C, Busse D, et al. Assessment Of Patient-Reported Health Status In Chronic Thromboembolic Pulmonary Arterial Hypertension Patients Treated With Riociguat: 2-Year Results From The Chest-2 Extension Study. Value Health. 2015 Nov;18(7):A398-9.
- Hoeper M.M, Mc Laughlin V.V, Dalaan A.M, Satoh T, Gali N. Treatment of pulmonary hypertension. Lancet Respir Med. 2016 Apr;4(4):323-36.
- Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347(5):322-9.
- Galie N, Humbert M, Vachiery J.L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119.
- Boucly A, Weatherald J, Savale L, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50(2):pii: 1700889.
- Radegran G, Kjellstrom B, Ekmehag B, et al. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014. Scand Cardiovasc J. 2016;50(4):243-50.
- Hoeper M.M, Huscher D, Pittrow D. Incidence and prevalence of pulmonary arterial hypertension in Germany. Int J Cardiol. 2016;203:612-3.
- Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry. Circulation. 2011;124:1973-81.
- Pepke-Zaba J, Jansa P, Kim N.H, et al. Chronic thromboembolic pulmonary hypertension: role of medical therapy. Eur Respir J. 2013;41(4):985-90.
- Lang I.M, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462-8.
- Kramm T, et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clinical Research in Cardiology. 2018;1-6.
- Мартынюк Т.В., Наконечников С.Н., Чазова И.Е. На пути оптимизации подходов к лечению хронической тромбоэмболической легочной гипертензии. Consilium Medicum. 2016;(5):53-8.
- Escribano-Subias P, Blanco I, Lopez-Meseguer M, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J. 2012;40:596-603.
- Rich S, Dantzker D.R, Ayres S.M, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216-23.
- Humpert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-30.
- Чазова И.Е., Архипова О.А., Мартынюк Т.В. Легочная артериальная гипертензия в России: анализ шестилетнего наблюдения по данным Национального регистра. Терапевтический архив. 2019;91(1):10-31. doi: 10.26442/00403660.2019.01.000024
- Валиева З.С., Валеева Э.Г., Глухова С.И., Мартынюк Т.В., Чазова И.Е. Разработка скринингового опросника для улучшения ранней диагностики легочной артериальной гипертензии. Системные гипертензии. 2014;11(4):62-7.
- Irene M. Lang, Gérald Simonneau, Joanna W. Pepke-Zaba, et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2013;110:83-91.
- Lang I.M, Pesavento R, Bonderman D, Yuan J.X. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462-8.
- Weatherald J, Huertas A, Boucly A, et al. Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension. Chest. 2018;154(4):872-81.
- Baptista R, Meireles J, Agapito A, et al. Pulmonary hypertension in Portugal: first data from a nationwide registry. Biomed Res Int. 2013;2013:489574.
- Austin C, Alassas K, Burger C, et al. Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. Chest. 2015;147:198-208.
- Чазова И.Е., Мартынюк Т.В., Филиппов Е.В. и др. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (II Часть). Терапевтический архив. 2016;88(10):63-73.
- Ling Y, Johnson M.K, Kiely D.G, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186(8):790-6.
- Badesch D.B, Raskob G.E, Elliott C.G, et al. Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry. Chest. 2010;137:376-87.
- Hoeper M.M, Huscher D, Ghofrani H.A, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168(2):871-80.
- Radegran G, Kjellstrom B, Ekmehag B, et al. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014. Scand Cardiovasc J. 2016;50(4):243-50.
- M.C.J van Thor, L ten Klooster, R.J Snijder, et al. Long - term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. IJC Heart&Vasculature. 2019;(22):163-8.
![](/img/style/loading.gif)